|
|
|
|
LEADER |
06764nma a2202089 u 4500 |
001 |
EB001963297 |
003 |
EBX01000000000000001126199 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
210512 ||| eng |
020 |
|
|
|a 9783039217557
|
020 |
|
|
|a 9783039217540
|
020 |
|
|
|a books978-3-03921-755-7
|
100 |
1 |
|
|a Olson, Anthony
|
245 |
0 |
0 |
|a Pharmacist Services
|h Elektronische Ressource
|
260 |
|
|
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2019
|
300 |
|
|
|a 1 electronic resource (436 p.)
|
653 |
|
|
|a community pharmacy practice
|
653 |
|
|
|a health policy
|
653 |
|
|
|a cystic fibrosis
|
653 |
|
|
|a value
|
653 |
|
|
|a comparative case study
|
653 |
|
|
|a community-based pharmacist practitioners
|
653 |
|
|
|a CMS Star rating
|
653 |
|
|
|a interprofessional
|
653 |
|
|
|a community-based pharmacy
|
653 |
|
|
|a gender disparities
|
653 |
|
|
|a innovation science
|
653 |
|
|
|a pharmaceutical regulation
|
653 |
|
|
|a history of pharmacy
|
653 |
|
|
|a continuity of patient care
|
653 |
|
|
|a brown bag
|
653 |
|
|
|a health care policy
|
653 |
|
|
|a transitions in care
|
653 |
|
|
|a clinical practice
|
653 |
|
|
|a readmissions
|
653 |
|
|
|a safety
|
653 |
|
|
|a community pharmacy services
|
653 |
|
|
|a quality measurement/benchmarking
|
653 |
|
|
|a care plan
|
653 |
|
|
|a management
|
653 |
|
|
|a federally qualified health center
|
653 |
|
|
|a chronic diseases
|
653 |
|
|
|a medication synchronization
|
653 |
|
|
|a multiple chronic conditions
|
653 |
|
|
|a adherence
|
653 |
|
|
|a pharmacy learners
|
653 |
|
|
|a primary care
|
653 |
|
|
|a communication
|
653 |
|
|
|a medication discrepancies
|
653 |
|
|
|a job satisfaction
|
653 |
|
|
|a ambulatory care
|
653 |
|
|
|a pharmacy education
|
653 |
|
|
|a organizations
|
653 |
|
|
|a design thinking
|
653 |
|
|
|a pharmacist
|
653 |
|
|
|a 21st century history
|
653 |
|
|
|a compensation
|
653 |
|
|
|a counselling
|
653 |
|
|
|a interprofessional training
|
653 |
|
|
|a interprofessional care
|
653 |
|
|
|a pharmaceutical care practice
|
653 |
|
|
|a emergency unit
|
653 |
|
|
|a medication safety
|
653 |
|
|
|a chronic kidney disease
|
653 |
|
|
|a interrupted time series analysis
|
653 |
|
|
|a serviced marketing
|
653 |
|
|
|a collaborative practice
|
653 |
|
|
|a age disparities
|
653 |
|
|
|a service process
|
653 |
|
|
|a immunization programs
|
653 |
|
|
|a value-added services
|
653 |
|
|
|a clinical pharmacy
|
653 |
|
|
|a opioid use disorder
|
653 |
|
|
|a observation
|
653 |
|
|
|a pharmacy practice
|
653 |
|
|
|a naltrexone
|
653 |
|
|
|a focus groups
|
653 |
|
|
|a medication reconciliation
|
653 |
|
|
|a job-related preferences
|
653 |
|
|
|a misuse
|
653 |
|
|
|a intention
|
653 |
|
|
|a interprofessional practice and education
|
653 |
|
|
|a regulatory
|
653 |
|
|
|a medication management
|
653 |
|
|
|a comprehensive medication management
|
653 |
|
|
|a cue orientation
|
653 |
|
|
|a mental health first aid
|
653 |
|
|
|a collaboration
|
653 |
|
|
|a medication use burden
|
653 |
|
|
|a South Asian
|
653 |
|
|
|a pharmacists
|
653 |
|
|
|a grants
|
653 |
|
|
|a Medicine and Nursing / bicssc
|
653 |
|
|
|a vaccination
|
653 |
|
|
|a pharmacy clinical services
|
653 |
|
|
|a naloxone
|
653 |
|
|
|a healthcare access
|
653 |
|
|
|a pharmacist roles
|
653 |
|
|
|a pharmacy benefit manager (PBM)
|
653 |
|
|
|a health workers
|
653 |
|
|
|a ethical models
|
653 |
|
|
|a immunization
|
653 |
|
|
|a pharmacy
|
653 |
|
|
|a comprehensive medication management services
|
653 |
|
|
|a n/a
|
653 |
|
|
|a 20th century history
|
653 |
|
|
|a medication-related problems
|
653 |
|
|
|a code of ethics
|
653 |
|
|
|a adverse drug events
|
653 |
|
|
|a qualitative research
|
653 |
|
|
|a retail clinics
|
653 |
|
|
|a pharmacy intern
|
653 |
|
|
|a experiential learning
|
653 |
|
|
|a mobile health units
|
653 |
|
|
|a HPV vaccination
|
653 |
|
|
|a ethics
|
653 |
|
|
|a theory of planned behavior.
|
653 |
|
|
|a decision-making
|
653 |
|
|
|a dispensing
|
653 |
|
|
|a community pharmacy
|
653 |
|
|
|a competitive advantage
|
653 |
|
|
|a Denmark
|
653 |
|
|
|a Comprehensive Medication Management
|
653 |
|
|
|a services marketing
|
653 |
|
|
|a medication therapy management
|
653 |
|
|
|a clinical results
|
653 |
|
|
|a cost avoidance
|
653 |
|
|
|a pharmacy practice faculty
|
653 |
|
|
|a pharmacy communication
|
653 |
|
|
|a billing
|
653 |
|
|
|a medication experience
|
653 |
|
|
|a pharmaceutical care
|
653 |
|
|
|a documentation
|
653 |
|
|
|a nurse practitioners
|
653 |
|
|
|a quality assurance
|
653 |
|
|
|a pharmacy services
|
653 |
|
|
|a information sharing
|
653 |
|
|
|a healthy people 2020
|
653 |
|
|
|a opioid
|
653 |
|
|
|a human papilloma virus
|
653 |
|
|
|a medication therapy problems
|
653 |
|
|
|a medication adherence
|
653 |
|
|
|a student pharmacist
|
653 |
|
|
|a counseling
|
653 |
|
|
|a focus group interviews
|
653 |
|
|
|a mental illness
|
653 |
|
|
|a pharmacist services
|
653 |
|
|
|a advanced practice pharmacist provider
|
653 |
|
|
|a implementation
|
653 |
|
|
|a comprehensive medication review
|
653 |
|
|
|a wellness programs
|
653 |
|
|
|a pharmacy staff
|
653 |
|
|
|a community pharmacists
|
653 |
|
|
|a coordinated care
|
653 |
|
|
|a travel
|
653 |
|
|
|a disposal
|
653 |
|
|
|a mental health care
|
653 |
|
|
|a primary health care
|
653 |
|
|
|a pharmacist workforce
|
653 |
|
|
|a pharmaceutical intervention
|
700 |
1 |
|
|a Schommer, Jon
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by-nc-nd/4.0/
|
028 |
5 |
0 |
|a 10.3390/books978-3-03921-755-7
|
856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/1767
|7 0
|x Verlag
|3 Volltext
|
856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/56132
|z DOAB: description of the publication
|
082 |
0 |
|
|a 000
|
082 |
0 |
|
|a 170
|
082 |
0 |
|
|a 370
|
082 |
0 |
|
|a 900
|
082 |
0 |
|
|a 610
|
082 |
0 |
|
|a 658
|
082 |
0 |
|
|a 140
|
082 |
0 |
|
|a 380
|
520 |
|
|
|a The overall goal of this book is to give the reader a state-of-the-art synopsis of the pharmacist services domain. To accomplish this goal, the authors have addressed the social, psychosocial, political, legal, historic, clinical, and economic factors that are associated with pharmacist services. In this book, you will gain cutting-edge insights from learning about the research of experts throughout the world. The findings have relevance for enhancing pharmacist professionalism, pharmacist practice, and the progression of pharmacist services in the future.
|